PurposeThe purpose of the present study was to collect medical resource utilization data and costs in Ontario for the management of patients with relapsed or refractory chronic lymphocytic lymphoma (cll) who have undergone at least 1 treatment course and have been stratified by Rai staging.Methods This retrospective longitudinal cohort study, conducted by chart review, analyzed anonymized patient records from two cancer centres in Ontario. Comprehensive records of 86 patients meeting the inclusion criteria were used to obtain resource utilization, which, multiplied by unit costs, were used to determine overall and mean costs. Descriptive statistics are presented for patient demographics, medical resource utilization, and costing data.
ResultsThe total cost for the cohort was $2.2 million over a mean follow-up period of 4.7 years. The mean total cost per patient (regardless of follow-up) was $25,736. In terms of Rai staging, overall mean costs were highest for stage iv patients. Almost 50% of the total cost was attributable to cll treatments, among which fludarabine-based treatments had the highest utilization.
ConclusionsFor this Canadian cll cohort, medical resource utilization and costs were determined to be $2.2 million, with cll treatments accounting for about half the cost. Costs generally increased with Rai stage.
A79and common comorbid conditions included diabetes (27.3%), tumor (23.6%) and moderate or severe renal disease (21.2%). Simvastatin (7.3%), lisinopril (5.9%) and hydrocodone bitartrate/acetaminophen (5.1%) were the most frequently prescribed medications. During the follow-up period, PC patients had evidence of the following health care utilizations: Medicare carrier (98.0%), Durable Medical Equipment (DME, 32.1%), Home Health Agency (HHA, 12.1%), outpatient visits (75.9%) and inpatient hospital (29.5%), Skilled Nursing Facility (SNF, 7.2%) and hospice admissions (5.4%) and prescription drug (part D event) claims (43.7%). PC patients incurred higher Medicare carrier
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.